Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jean M Shen
Safety and Immunogenicity of a Gag-Pol Candidate HIV-1 DNA Vaccine Administered by a Needle-Free Device in HIV-1-Seronegative Subjects
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
Related publications
Randomised, Placebo-Controlled, Phase I/IIa Evaluation of the Safety and Immunogenicity of Fowlpox Virus Expressing HIV Gag-Pol and Interferon-? In HIV-1 Infected Subjects
Human Vaccines
Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype C Gag Vaccine in Healthy HIV-1-Uninfected Adults
Clinical and Vaccine Immunology
Medicine
Immunology
Allergy
Clinical Biochemistry
Microbiology
Nef Modulates the Immunogenicity of Gag Encoded in a Non-Infectious HIV DNA Vaccine
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
A Rev-Independent Human Immunodeficiency Virus Type 1 (HIV-1)-Based Vector That Exploits a Codon-Optimized HIV-1 Gag-Pol Gene
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Regulation of HIV-1 Gag-Pol Expression by Shiftless, an Inhibitor of Programmed -1 Ribosomal Frameshifting
Cell
Biochemistry
Genetics
Molecular Biology
Safety, Tolerability, and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV-Infected Patients Receiving Combination Antiretroviral Therapy
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
The Safety and Immunogenicity of GTU®MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART
Frontiers in Immunology
Allergy
Immunology
First-In-Human Phase 1 Trial of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 5 HVR48 (rAd5HVR48) HIV-1 Vaccine
Retrovirology
Virology
Infectious Diseases
The Safety and Immunogenicity of an Interleukin-12–Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
